COMPUMEDICS LIMITED — Regulatory Filings 2016

Jun 29, 2016

==> picture [74 x 76] intentionally omitted <==

ASX Announcement 30 June 2016

4-part question and answer session

Compumedics Limited (ASX: CMP) ( “Compumedics” and “Company” ) is currently running a series of question and answer sessions, via Proactive Investor services, which contain information on the Company the market may find useful.

As such, links to the first two sessions are below:

Week one:

http://www.compumedics.com.au/PIQA1

Week two:

http://www.compumedics.com.au/QA290616

About Compumedics Limited

Compumedics Limited (ASX: CMP) is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The Company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including Americas; Australia and Asia Pacific; and Europe and the Middle East.

Executive Chairman, Dr David Burton, founded Compumedics in 1987. In the same year the Company successfully designed and installed the first Australian, fully computerised Sleep Clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets. Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards and accolades including Australia’s exporter of the year and has been recognised as a Top 100 Innovator by both German and Australian Governments.

==> picture [74 x 76] intentionally omitted <==

For further background please visit: www.compumedics.com

For further information please contact:

Dr David Burton , Executive Chairman, CEO Compumedics Limited T: + 61 3 8420 7300

Mr David Lawson , Executive Director, CFO Compumedics Limited T: + 61 3 8420 7300 F: +61 3 8420 7399

For investor relations and media enquiries please contact:

Rod North , Managing Director, Bourse Communications Pty Ltd T: (03) 9510 8309, M: 0408 670 706 E: rod@boursecommunications.com.au